A
43.02
1.00 (2.38%)
Previous Close | 42.02 |
Open | 42.33 |
Volume | 433,385 |
Avg. Volume (3M) | 409,824 |
Market Cap | 2,029,842,816 |
Price / Earnings (Forward) | 51.81 |
Price / Sales | 4.17 |
Price / Book | 4.45 |
52 Weeks Range | |
Earnings Date | 6 Nov 2025 |
Profit Margin | -5.49% |
Operating Margin (TTM) | -0.69% |
Diluted EPS (TTM) | -0.510 |
Quarterly Revenue Growth (YOY) | 1.60% |
Total Debt/Equity (MRQ) | 123.15% |
Current Ratio (MRQ) | 5.53 |
Operating Cash Flow (TTM) | 10.78 M |
Levered Free Cash Flow (TTM) | -14.03 M |
Return on Assets (TTM) | 1.54% |
Return on Equity (TTM) | -7.26% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (US) | Mixed | Bearish |
Medical Devices (Global) | Mixed | Bearish | |
Stock | Artivion, Inc. | Bullish | Bullish |
AIStockmoo Score
-0.4
Analyst Consensus | -1.5 |
Insider Activity | NA |
Price Volatility | -3.0 |
Technical Moving Averages | 3.5 |
Technical Oscillators | -0.5 |
Average | -0.38 |
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company’s products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. |
|
Sector | Healthcare |
Industry | Medical Devices |
Investment Style | Small Growth |
% Held by Insiders | 5.01% |
% Held by Institutions | 98.14% |
Ownership
Name | Date | Shares Held |
---|---|---|
Perceptive Advisors Llc | 30 Jun 2025 | 2,793,703 |
52 Weeks Range | ||
Price Target Range | ||
High | 50.00 (Needham, 16.23%) | Buy |
Median | 41.00 (-4.70%) | |
Low | 38.80 (Ladenburg Thalmann, -9.81%) | Hold |
Average | 42.36 (-1.53%) | |
Total | 4 Buy, 1 Hold | |
Avg. Price @ Call | 42.28 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Needham | 22 Aug 2025 | 50.00 (16.23%) | Buy | 44.83 |
08 Aug 2025 | 45.00 (4.60%) | Buy | 40.95 | |
Ladenburg Thalmann | 13 Aug 2025 | 38.80 (-9.81%) | Hold | 43.73 |
Canaccord Genuity | 08 Aug 2025 | 41.00 (-4.70%) | Buy | 40.95 |
JMP Securities | 08 Aug 2025 | 42.00 (-2.37%) | Buy | 40.95 |
Stifel | 08 Aug 2025 | 40.00 (-7.02%) | Buy | 40.95 |
No data within this time range.
Date | Type | Details |
---|---|---|
05 Sep 2025 | Announcement | Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference |
07 Aug 2025 | Announcement | Artivion Reports Second Quarter 2025 Financial Results |
30 Jul 2025 | Announcement | Artivion to Participate in Upcoming Investor Conferences |
24 Jul 2025 | Announcement | Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2025 Financial Results |
5Y Average Dividend Yield | 0.00% |
Ex Date | Announcement Date | Payment Date | Details |
---|---|---|---|
09 Dec 2015 | 22 Oct 2015 | 18 Dec 2015 | 0.03 Cash |
09 Sep 2015 | 22 Jul 2015 | 18 Sep 2015 | 0.03 Cash |
10 Jun 2015 | 21 May 2015 | 19 Jun 2015 | 0.03 Cash |
11 Mar 2015 | 13 Feb 2015 | 20 Mar 2015 | 0.03 Cash |
10 Dec 2014 | 23 Oct 2014 | 19 Dec 2014 | 0.03 Cash |
10 Sep 2014 | 30 Jul 2014 | 19 Sep 2014 | 0.03 Cash |
11 Jun 2014 | 22 May 2014 | 20 Jun 2014 | 0.03 Cash |
12 Mar 2014 | 19 Feb 2014 | 21 Mar 2014 | 0.0275 Cash |
11 Dec 2013 | 21 Nov 2013 | 20 Dec 2013 | 0.0275 Cash |
11 Sep 2013 | 21 Aug 2013 | 20 Sep 2013 | 0.0275 Cash |
12 Jun 2013 | 28 May 2013 | 21 Jun 2013 | 0.0275 Cash |
12 Mar 2013 | 13 Feb 2013 | 21 Mar 2013 | 0.025 Cash |
12 Dec 2012 | 19 Nov 2012 | 21 Dec 2012 | 0.025 Cash |
12 Sep 2012 | 21 Aug 2012 | 21 Sep 2012 | 0.025 Cash |
Show more |
Annual Dividend Yield
Year | Annual Dividend ($) | Frequency/Year | Yield % |
---|---|---|---|
2015 | 0.120 | 4 | 1.11 |
2014 | 0.118 | 4 | 1.04 |
2013 | 0.108 | 4 | 0.97 |
2012 | 0.050 | 2 | 0.80 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |